Market Place
Sourcing Support
TiumBio Doses First Patient In Phase 2 Trial Of TU2218
04 Oct 2024 //
PR NEWSWIRE
TiumBio Presents Promising Data For Hemophilia Treatment TU7710 At ISTH 2024
24 Jun 2024 //
PR NEWSWIRE
TiumBio`s TU2218 Plus Pembro Phase 1b Interim Results At ASCO 2024
01 Jun 2024 //
PR NEWSWIRE
TiumBio Positive Topline Phase 2a Data For Merigolix In Endometriosis
08 May 2024 //
PR NEWSWIRE
TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710
26 Mar 2024 //
PR NEWSWIRE
TiumBio Secures KRW 38.5 Billion in Anticipation of Upcoming Clinical Data
29 Dec 2023 //
PR NEWSWIRE
TiumBio and Hansoh Announce Trial Approval of `HS-10518/TU2670`
05 Jul 2023 //
PR NEWSWIRE
TiumBio inks licensing deal with China`s Hansoh for endometriosis drug
10 Aug 2022 //
KEDGLOBAL
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.